Arjo AB (publ) (FRA:A39)

Market Cap	800.94M
Revenue (ttm)	1.01B
Net Income (ttm)	39.62M
Shares Out	n/a
EPS (ttm)	0.15
PE Ratio	20.22
Forward PE	13.43
Dividend	0.09 (2.97%)
Ex-Dividend Date	Apr 30, 2025

Volume	n/a
Average Volume	35
Open	2.918
Previous Close	2.888
Day's Range	2.918 - 2.918
52-Week Range	2.662 - 3.628
Beta	n/a
RSI	59.73
Earnings Date	Jan 27, 2026

About Arjo AB

Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and Pacific. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, prevention of deep vein thrombosis and treatment of edema, leg ulcer treatment and prevention, and for obstetric and cardiac diagnostics. The company also provides dementia care, bariatric room solutions, prone positioning, early mobili...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1957
• Employees: 7,173
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: A39

Financial Performance

In 2024, Arjo AB's revenue was 11.29 billion, an increase of 2.84% compared to the previous year's 10.98 billion. Earnings were 498.00 million, an increase of 3.75%.

Financial numbers in SEK